Deal-Making
MIT receives $82m from FDA for continuous mRNA manufacturing platform
Deal MakingMIT receives $82m from FDA for continuous mRNA manufacturing platformMIT receives $82m from FDA for continuous mRNA manufacturing platform
With $82 million in FDA funding, MIT will conduct a three-year research program to design a fully integrated continuous mRNA platform.